Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Novartis
Express Scripts
Moodys
Dow
US Army
Julphar
Johnson and Johnson
Daiichi Sankyo

Generated: January 22, 2018

DrugPatentWatch Database Preview

TOLAZAMIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tolazamide and what is the scope of tolazamide patent protection?

Tolazamide
is the generic ingredient in two branded drugs marketed by Barr, Duramed Pharms Barr, G And W Labs Inc, Interpharm, Mylan Pharms Inc, Par Pharm, Sandoz, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, and Pharmacia And Upjohn, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tolazamide. Two suppliers are listed for this compound.
Pharmacology for TOLAZAMIDE
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for TOLAZAMIDE

US Patents and Regulatory Information for TOLAZAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma TOLAZAMIDE tolazamide TABLET;ORAL 071355-001 Jan 11, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TOLAZAMIDE tolazamide TABLET;ORAL 070514-001 Jan 9, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries TOLAZAMIDE tolazamide TABLET;ORAL 071357-001 Jul 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm TOLAZAMIDE tolazamide TABLET;ORAL 070160-001 Jan 6, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TOLAZAMIDE tolazamide TABLET;ORAL 070289-001 Mar 13, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Interpharm TOLAZAMIDE tolazamide TABLET;ORAL 071270-001 Sep 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr TOLAZAMIDE tolazamide TABLET;ORAL 070166-001 Jan 10, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chubb
Farmers Insurance
McKinsey
Boehringer Ingelheim
Harvard Business School
Express Scripts
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot